Skip to main content

Table 1 EVL/MIR342 methylation frequency in NHL primary samples

From: Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy

Disease subtype

Sample size

Methylation (%)

B-NHLs

99

68 (68.69%)

 Diffuse large B cell lymphoma (DLBCL)

56

42 (75.00%)

 Follicular lymphoma (FL)

6

4 (66.67%)

 Mantle cell lymphoma (MCL)

17

4 (23.53%)

 Burkitt’s lymphoma (BL)

5

4 (80.00%)

 Mucosa-associated lymphoid tissue lymphoma (MALT)

4

4 (100.0%)

 Marginal zone B cell lymphoma (MZBCL)

3

2 (66.67%)

 Small lymphocytic lymphoma (SLL)

7

7 (100.00%)

 Waldenstrom’s macroglobulinemia (WM)

1

1 (100.00%)

T-NHLs

33

8 (24.24%)

 Peripheral T cell lymphoma (PTCL)

20

5 (25.00%)

 Angioimmunoblastic T cell lymphoma (AITL)

13

3 (23.08%)